NYSE· Commercial Banks, NEC· CIK 0000890541

BLX

BLADEX, INC.
$54.78 ▼ -0.79%
Prev close $55.21
Market cap$2.1B
12-mo target$65.90 (+20.3%)
Insider Buying Cluster (2 insiders)High Impact Filing (7/10) Traditional Finance
Snapshot
The big-picture read on BLX right now — valuation, ownership and activity at a glance.
Market Cap
$2.1B
Cap Size
Mid Cap
Insider Activity
$178.0K buy / $0.00 sell
Insider Net $
$178.0K
SEC Reports
4
Price chart 30d -1.9%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 15, 2026 other
Bladex Structures USD 1.0 Billion Loan for the Republic of Panama
The transaction, the largest structured and granted by Bladex, enables the Republic of Panama to acc
Sep 1, 2026 SEC
Two C-suite insiders at BLX (CFO and CRO) made open-market purchases totaling $178K over a one-week window. The combined
CLUSTER — Impact 2/10
Aug 28, 2026 Insider
Van Hoorde Annette Marie bought 1,454 shares
Chief Financial Officer @ $55.00 ($80.0K)
Aug 21, 2026 Insider
Tizzoni Alejandro Horacio bought 1,850 shares
Chief Risk Officer @ $53.00 ($98.0K)
Aug 3, 2026 SEC
Bladex reported Q2 2026 total revenues of $98.9M (+9.8% YoY) and net income of $66.5M (+3.5% YoY), with EPS of $1.77 (+2
6-K — Impact 5/10
Jun 8, 2026 SEC
Bladex (BLX) filed a 6-K announcing that its corporate name has been formally changed to Bladex, Inc., effective June 4,
6-K — Impact 2/10
Jun 1, 2026 Insider
Gomes Tarciana Paula disposed of 4,200 shares
Director @ $55.09 ($231.4K)
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
DateFirmActionRatingFirm rating
Oct 16, 2023JefferiesINITIATEBuy 53%
Jun 29, 2023BarclaysINITIATEOverweight 54%
Jul 21, 2017JP MorganDOWNGRADEUnderweight 55%
Oct 20, 2016JP MorganDOWNGRADENeutral 55%
Jun 5, 2014JP MorganMAINTAINOverweight 55%
Jun 22, 2012JP MorganUPGRADEOverweight 55%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 20262510088%
Aug 1, 20262510088%
Jul 1, 20262510088%
Jun 1, 20262510088%
May 1, 20262610089%
Apr 1, 20262610089%
Mar 1, 20261610088%
Feb 1, 20261610088%
Price targets
Where 4 covering analysts think BLX trades over the next 12 months.
$65.90 +20.3% upside Strong Buy
Current$54.78 Low$57.00 Median$66.80 High$73.00 4 analysts
$57.00$73.00
Analyst rating Strong Buy· 1.3/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
4 SEC filing reports analyzed · 1 bullish, 0 bearish, 1 mixed, 2 neutral · avg impact 4.0/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 15, 2026
other
Bladex Structures USD 1.0 Billion Loan for the Republic of Panama
The transaction, the largest structured and granted by Bladex, enables the Republic of Panama to access funding in an agile manner under competitive t
Sep 8, 2026
other
Bladex completes successful Debt Issuance in The Mexican Capital Markets
PANAMA CITY, Sept. 8, 2026 /PRNewswire/ -- Bladex, Inc. (NYSE: BLX) announced the successful placement of long-term Mexican notes (Cebures) in Mexico'
Jul 27, 2026
earnings_calendar
BLX Q2 2026 Earnings Scheduled — 2026-07-27
Apr 27, 2026
earnings_calendar
BLX Q1 2026 Earnings Scheduled — 2026-04-27
Feb 17, 2026
short_interest
FTD: BLX — 10,000 shares ($0.5M) failed to deliver
Settlement: 20260217, Price: $51.17, FTD Value: $511,700, BANCO LATINOAMERICANO DE COMER
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$0.00$0.00–$0.00———$0.0B—
Next Q$0.00$0.00–$0.00———$0.0B—
Current FY$6.47$6.09–$6.866.0%-5.6%1↑ 0↓$0.4B2
Next FY$7.04$6.57–$7.518.7%-0.2%1↑ 0↓$0.4B2
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
3 insiders, 3 transactions. Net $178.0K — $178.0K bought, $0.00 sold.
DateInsiderTitleTypeSharesPriceValue
Aug 28, 2026Van Hoorde Annette MarieChief Financial OfficerBUY1,454$55.00$80.0K
Aug 21, 2026Tizzoni Alejandro HoracioChief Risk OfficerBUY1,850$53.00$98.0K
Jun 1, 2026Gomes Tarciana PaulaDirector—4,200$55.09$231.4K
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for BLX.
Shares short
708,379
Settlement Sep 15, 2026
Change vs prior
+53.6%
Semi-monthly cycle
Days to cover
4.4
At avg daily volume
Of shares outstanding
≈1.9%
Estimate — not % of float
All BLX filing & press-release reports (4)